The aim of the current study was to determine whether plasma levels of procalcitonin, CRP, and lactate, which are routinely measured in patients with suspected infection or sepsis in our ED, could be combined with clinical information to accurately predict mortality rates and risk-stratify cancer patients in the ED with suspected infection. The gene discussed is CRP; the disease is infection.